Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Corporate Action Announcement

· NSE 🔴 High Importance Neutral
📢 Key Event
Apollo Hospitals proposes composite scheme of arrangement for Apollo Healthtech governance and Upside Agreement approval
🔄 What Changed
Board composition with six independent directors; appointment of Ms. Shobana Kamineni as Executive Chairperson; Upside Agreement tied to 4x MOIC target with 9% upside share; fall-away threshold for nomination rights below 10%
🔮 What's Next
Approval of the scheme by shareholders of Apollo Hospitals and subsequent approval by public shareholders of Apollo Healthtech post-listing
💡 Investor Takeaway
Shareholders must approve the scheme, which restructures Apollo Healthtech with new governance and performance-linked incentives without financial burden.

Apollo Hospitals announced a composite scheme of arrangement involving Apollo Healthtech Limited, Transferor Company 1, and Transferor Company 2, seeking shareholder and creditor approvals under Sections 230-232 of the Companies Act, 2013. The proposal includes governance reforms for Apollo Healthtech, such as a six-member board with independent directors, appointment of Ms. Shobana Kamineni as Executive Chairperson, and board nomination rights subject to a 10% fall-away threshold. The scheme also details an investor-funded Upside Agreement tied to performance targets, with no dilution to Apollo Healthtech's financial position. Approval requires majority support from public shareholders of both Apollo Hospitals and Apollo Healthtech post-listing.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.